New details on the new health wearable Apple (NSDQ:AAPL) is said to be developing emerged yesterday when the U.S. Patent & Trademark Office released a patent application for a wrist- or ankle-worn device with electrocardiology features.
That fits in with rumors that surfaced earlier this week of Apple’s plan to develop a stand-alone device to monitor heart rate, pulse, blood and sugar changes. CEO Tim Cook has said that the healthcare market’s potential could dwarf the smartphone market that accounts for some 65% of Apple’s $234 billion in annual revenues.
The patent application details a device that could detect on which arm or ankle it’s being worn and generate electrocardiographic readings using its 3 electrode sensors. The device is also designed to put through an “enrollment procedure” in which it’s worn on each wrist and ankle, enabling it to compare those baseline readings against later enrollment measurements to determine which limb is being used.
Cupertino, Calif.-based Apple is said to be readying a 2017 launch for the health wearable, tapping suppliers in Taiwan and China as it finalizes the product. The device will rely on the touch-sensitive “3D Touch” home button featured in the iPhone 6s, according to media reports. Apple’s technical director Jay Blahnik and the company’s health-focused development team have reportedly been working on the device for more than 2 years.
The next iteration of the iPhone will also feature health-sensing technology, according to the reports.